"Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial" by Jacob S. Parzen

Article

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial

Advances in radiation oncology (2021)

Jacob S. Parzen, Oakland University
Michael D. Chuong, Miami Cancer Institute, Department of Radiation Oncology, Miami, Florida
John Chang, Northwestern Medicine Chicago Proton Center, Department of Radiation Oncology, Warrenville, Illinois
Lane Rosen, Willis-Knighton Cancer Center, Department of Radiation Oncology, Shreveport, Louisiana
James Urbanic, California Protons Therapy Center, Department of Radiation Oncology, San Diego, California
William Hartsell, Northwestern Medicine Chicago Proton Center, Department of Radiation Oncology, Warrenville, Illinois
Henry Tsai, Princeton University
Christopher Sinesi, Hampton University
Jing Zeng, Seattle Cancer Care Alliance
Mark Mishra, Maryland Proton Treatment Center, Department of Radiation Oncology, Baltimore, Maryland
Carlos Vargas, Mayo Clinic
Craig Stevens, Oakland University
Peyman Kabolizadeh, Oakland University

Link Find in your library

Disciplines

Publication Date

September 1, 2021

DOI

10.1016/J.ADRO.2021.100751

Citation Information

Jacob S. Parzen, Michael D. Chuong, John Chang, Lane Rosen, et al.. "Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial" Advances in radiation oncology Vol. 6 Iss. 5 (2021) p. 100751
Available at: http://works.bepress.com/michael-chuong/131/